Octreotide
Also known as: sandostatin, octreotide acetate, SMS 201-995, somatostatin analogue octreotide
Potent somatostatin analogue widely used in research for GH suppression and neuroendocrine tumor control.
Quick Reference
Octreotide - Research Images
PSO vial render · Scientific images from Wikipedia · Tap to enlarge
Overview
Octapeptide that mimics natural somatostatin pharmacologically
Octreotide, sold under the brand name Sandostatin among others, is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979 and binds predominantly to the somatostatin receptors SSTR2 and SSTR5.
Mechanism of Action
Octreotide, sold under the brand name Sandostatin among others, is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979 and binds predominantly to the somatostatin receptors SSTR2 and SSTR5.
What Researchers Are Saying
Community Reports - Not Medical Advice
The following is aggregated from public forums, Reddit, and research communities. These are anecdotal reports from researchers only - not verified clinical data and not a recommendation of any kind.
Octreotide (also known as sandostatin, octreotide acetate) is studied within the peptide research community. Potent somatostatin analogue widely used in research for GH suppression and neuroendocrine tumor control.
Last updated October 28, 2026
Research status: active. Octreotide appears across peptide research forums and academic literature. Researchers note this compound falls in the other category.
Last updated October 28, 2026
What Do You Think of This Peptide?
Share your opinion or research experience with Octreotide. Comments are reviewed before appearing.